Table 1.
Participant characteristics of anthropometric measurements and blood test at baseline (T0) and at the end of the study (T45).
| T 0 | T 45 | p < 0.05 | |
|---|---|---|---|
| Weight (Kg) | 96.8 ± 12.9 | 91.3 ± 13.1 | 0.162 |
| Body Mass Index (Kg/m2) | 37.6 ± 4.4 | 35.7 ± 4.2 | 0.044 * |
| Waist Circumference (cm) | 107 ± 7.4 | 102.4 ± 7.3 | 0.042 * |
| Thigh Circumference (cm) | 62.4 ± 2.8 | 60.4 ± 2.6 | 0.046 * |
| Systolic Body Pressure (mmHg) | 127 ± 11 | 120 ± 11 | 0.066 |
| Diastolic Body Pressure (mmHg) | 75 ± 7 | 70 ± 10 | 0.060 |
| Fasting Glycemia (mg/dL) | 112 ± 23.9 | 105.4 ± 14.2 | 0.145 |
| Fasting Insulin (μIU/mL) | 17.4 ± 7.7 | 10.4 ± 3.9 | 0.001 * |
| HOMA Index | 4.8 ± 2.2 | 2.3 ± 1.1 | 0.001 * |
| Hb1AC (%) | 5.96 ± 0.6 | 5.67 ± 0.3 | 0.053 |
| BUN (mg/dL) | 36.1 ± 7.8 | 46.3 ± 18.5 | 0.026 * |
| Creatinine (mg/dL) | 0.79 ± 0.2 | 0.86 ± 0.2 | 0.192 |
| eGFR | 124.2 ± 36.2 | 110.2 ± 37.2 | 0.140 |
| Na (mmol/L) | 142.1 ± 2.1 | 140.7 ± 2 | 0.030 * |
| K (mmol/L) | 4.4 ± 0.3 | 4.5 ± 0.3 | 0.280 |
| Cl (mmol/L) | 100 ± 1.7 | 99 ± 1.8 | 0.076 |
| Ca (mg/dL) | 9.6 ± 0.4 | 9.7 ± 0.5 | 0.230 |
| Mg (mg/dL) | 2.0 ± 0.1 | 2.2 ± 0.1 | 0.002 * |
| P (mg/dL) | 3.5 ± 0.5 | 3.7 ± 0.4 | 0.100 |
| AST (U/L) | 17.5 ± 5.4 | 19.5 ± 4.2 | 0.128 |
| ALT (U/L) | 21.2 ± 12.6 | 23.2 ± 11.4 | 0.321 |
| Total Cholesterol (mg/dL) | 224 ± 56 | 207 ± 47 | 0.177 |
| LDL Cholesterol (mg/dL) | 140 ± 53 | 128 ± 47 | 0.243 |
| HDL Cholesterol (mg/dL) | 57 ± 13 | 55 ± 11 | 0.294 |
| Triglycerides (mg/dL) | 132 ± 39 | 120 ± 35 | 0.192 |
| Uric acid (mg/dL) | 5.2 ± 1.4 | 5.3 ± 1.4 | 0.424 |
| CRP (mcg/L) | 7686 ± 6509 | 5643 ± 4973 | 0.166 |
| ESR (mm/h) | 36 ± 15 | 38 ± 18 | 0.412 |
Abbreviations: BUN, blood urea nitrogen; eGFR, estimated Glomerular Filtration Rate; AST, aspartate transaminase; ALT, alanine transferase; CRP, C reactive protein; ESR, erythrocite sedimentation rate. All values are presented as mean ± standard deviation. * p < 0.05.